COMPANY PROFILE

Allozymes

A leading deep technology company that applies its proprietary microfluidics technology to develop custom-designed enzymes for cleaner and sustainable manufacturing of complex natural products

Singapore, SingaporeFounded 2019Wellness Beauty

Valuation $50–100M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Allozymes

Allozymes is a biotechnology company that leverages its proprietary microfluidics technology to rapidly develop novel enzymes, transforming the way industries manufacture complex natural products. The company serves clients across various sectors, including pharmaceuticals, cosmetics, and food and beverage. Operating in the enzyme engineering market, Allozymes collaborates with GenScript to provide comprehensive protein engineering services. The business model revolves around offering screening services and constructing mutant libraries for diverse applications. Revenue is generated through service contracts and partnerships with industry players.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2019
Headquarters: Singapore, Singapore
Employees: 31
Open positions: None listed
Dealroom signal: 70.8/100
Industry: Wellness Beauty, Chemicals
Sector: Wellness Beauty, Biotechnology, Biomaterials, Sustainable Development Goals, Biotech and Pharma, Climate Tech, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	May 2024	$15M	$60M	Seventure Partners · ID Capital · Transpose Platform · NUS Technology Holdings	↗
SERIES A✓Equity / VC	Aug 2023	—	—	Xora Innovation · Seventure Partners	↗

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Allozymes website traffic

Latest recorded traffic for Allozymes is 1.5K monthly website visits, up 900% over the last three months. Allozymes's team grew 0% over the past year.

Latest monthly visits1.5K 3-month web change+900% 1-year team growth0%

Monthly website visitsJan 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
BIBioworksPlant-derived synthetic fibers replacing petroleum-based plastics	Tokyo, Japan	Acquired	2	$4.3M	$4.6M
DCDUDE CHEMEnables greener outsourcing of active pharmaceutical ingredients and their intermediates in order to transform the current pharma-chemical industry towards an environmentally benign sector	Berlin, Germany	Operational
CHCheckerspotHigh performance materials company that designs materials at a molecular level	Berkeley, United States	Operational
PIPiliBiofabricates a sustainable alternative to produce low-carbon colors to replace toxic, fossil based and polluting versions	Toulouse, France	Operational
CECELLUGYBiotechnology company focused on the development of nanocellulose polymers for a variety of end-markets	Gladsaxe Municipality, Denmark	Operational
CLCleanJouleInnovators and producers of Sustainable Aviation Fuel (SAF)	West Valley City, United States	Operational
LSLocus Fermentation SolutionsLeading the ESG revolution by fermenting award-winning, green solutions to the biggest global challenges	Australia	Operational
CACapro-XUsing our "WheyAway" sustainable ag-tech to tackle dairy wastes and produce palm oil chemical substitutes	Ithaca, United States	Operational